Access cutting-edge brain cancer treatment through this clinical trial at a research site in Ann Arbor. Study-provided care at no cost to qualified participants.
Access brain cancer specialists in Ann Arbor at no cost
This study follows strict safety protocols and ethical guidelines
All study-related brain cancer treatment provided free
The goal of this study is to determine the efficacy of the study drugs ribociclib and everolimus to treat pediatric and young adult patients newly diagnosed with a high-grade glioma (HGG), including DIPG, that have genetic changes in pathways (cell cycle, PI3K/mTOR) that these drugs target. The main question the study aims to answer is whether the combination of ribociclib and everolimus can prolong the life of patients diagnosed with HGG, including DIPG.
Sponsor: Nationwide Children's Hospital
Check if you qualify for this brain cancer clinical trial in Ann Arbor, MI
If you're searching for brain cancer treatment options in Ann Arbor, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Ann Arbor research site is actively enrolling participants for this clinical trial. You'll receive care from experienced brain cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.